What is Chrono-log?
CHRONO-LOG is a specialized entity focused on the design, development, and manufacturing of cutting-edge platelet technologies. These innovations are crucial for enhancing platelet function testing within both clinical and research laboratory settings. The company's comprehensive suite of platelet tests is indispensable for accurately diagnosing platelet function defects, effectively monitoring patients undergoing anti-platelet drug therapies, and supporting researchers in the development of novel therapeutic interventions. By providing tools to identify bleeding or thrombosis risks and optimize drug regimens, CHRONO-LOG aims to elevate patient care standards and contribute to the reduction of overall healthcare expenditures. Their offering includes a complete range of aggregation systems, reagents, and associated supplies, positioning them as a comprehensive provider for all platelet testing requirements.
How much funding has Chrono-log raised?
Chrono-log has raised a total of $483K across 2 funding rounds:
Debt
$150K
Debt
$333K
Debt (2020): $150K with participation from PPP
Debt (2021): $333K led by PPP
What's next for Chrono-log?
With the recent influx of capital, Chrono-log is strategically positioned for significant expansion. The large-scale, late-stage funding indicates a transition from development to market penetration and operational scaling. Expect Chrono-log to enhance its manufacturing capabilities, broaden its sales and distribution networks, and potentially invest further in research and development to maintain its competitive edge in innovative platelet diagnostics. This investment will likely fuel strategic partnerships and market consolidation efforts within the specialized field of hematology and diagnostics.
See full Chrono-log company page
